Examination of the Effects of Financial Risk on the Formal Treatment Costs for a Medicaid Population with Psychiatric Disabilities

Examination of the Effects of Financial Risk on the Formal Treatment Costs for a Medicaid Population with Psychiatric Disabilities

Objectives: We examined the effects of differing financial risk arrangements for mental health, physical health, and pharmacy services on the overall costs of these services with particular attention to cost containment and cost shifting. Methods: Comprehensive service utilization information was ob...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Medical Care. - Lippincott Williams & Wilkins, a business of Wolters Kluwer Health, 1963. - 44(2006), 4, Seite 320-327
1. Verfasser: Jones, Kristine (VerfasserIn)
Weitere Verfasser: Chen, Huey Jen, Jordan, Neil, Boothroyd, Roger A., Ramoni-Perazzi, Josefa, Shern, David L.
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2006
Zugriff auf das übergeordnete Werk:Medical Care
Schlagworte:Cost analysis Financing Managed care Mental disorders
LEADER 01000caa a22002652 4500
001 JST057269556
003 DE-627
005 20230505024410.0
007 cr uuu---uuuuu
008 150325s2006 xx |||||o 00| ||eng c
035 |a (DE-627)JST057269556 
035 |a (JST)3768324 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
082 0 4 |a 610  |q ASE 
084 |a 44.10  |2 bkl 
100 1 |a Jones, Kristine  |e verfasserin  |4 aut 
245 1 0 |a Examination of the Effects of Financial Risk on the Formal Treatment Costs for a Medicaid Population with Psychiatric Disabilities 
264 1 |c 2006 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Objectives: We examined the effects of differing financial risk arrangements for mental health, physical health, and pharmacy services on the overall costs of these services with particular attention to cost containment and cost shifting. Methods: Comprehensive service utilization information was obtained from a sample of 458 adults with severe mental illnesses during a 12-month period. Rate information was used to calculate costs for health, mental health and pharmacy. A 2-part model was employed to test for differences among financial risk conditions. Results: Total treatment costs, both those financed by Medicaid and those paid by other sources, were lower in plans that had a broader array of services for which they were at risk. Pharmacy costs were principally responsible for these differences. Conclusions: Treatment costs for adults with severe mental illnesses can be contained by placing providers at financial risk. However, risk arrangements may also increase treatment costs borne by other payers including charity services and self-pay. Evaluating the impact of at-risk financing mechanisms from a public health perspective requires assessing cost shifting, particularly for pharmaceuticals. 
540 |a Copyright 2006 Lippincott Williams & Wilkins 
650 4 |a Cost analysis 
650 4 |a Financing 
650 4 |a Managed care 
650 4 |a Mental disorders 
655 4 |a research-article 
700 1 |a Chen, Huey Jen  |e verfasserin  |4 aut 
700 1 |a Jordan, Neil  |e verfasserin  |4 aut 
700 1 |a Boothroyd, Roger A.  |e verfasserin  |4 aut 
700 1 |a Ramoni-Perazzi, Josefa  |e verfasserin  |4 aut 
700 1 |a Shern, David L.  |e verfasserin  |4 aut 
773 0 8 |i in  |t Medical Care  |d Lippincott Williams & Wilkins, a business of Wolters Kluwer Health, 1963  |g 44(2006), 4, Seite 320-327  |w (DE-627)328558575  |w (DE-600)2045939-7  |x 15371948  |7 nnns 
773 1 8 |g volume:44  |g year:2006  |g number:4  |g pages:320-327 
856 4 0 |u https://www.jstor.org/stable/3768324  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_JST 
912 |a SSG-OLC-PHA 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_23 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_32 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_62 
912 |a GBV_ILN_63 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_73 
912 |a GBV_ILN_74 
912 |a GBV_ILN_90 
912 |a GBV_ILN_95 
912 |a GBV_ILN_100 
912 |a GBV_ILN_101 
912 |a GBV_ILN_105 
912 |a GBV_ILN_110 
912 |a GBV_ILN_120 
912 |a GBV_ILN_121 
912 |a GBV_ILN_150 
912 |a GBV_ILN_151 
912 |a GBV_ILN_152 
912 |a GBV_ILN_161 
912 |a GBV_ILN_170 
912 |a GBV_ILN_187 
912 |a GBV_ILN_206 
912 |a GBV_ILN_266 
912 |a GBV_ILN_285 
912 |a GBV_ILN_293 
912 |a GBV_ILN_370 
912 |a GBV_ILN_374 
912 |a GBV_ILN_602 
912 |a GBV_ILN_647 
912 |a GBV_ILN_702 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2007 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2009 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2011 
912 |a GBV_ILN_2014 
912 |a GBV_ILN_2015 
912 |a GBV_ILN_2018 
912 |a GBV_ILN_2020 
912 |a GBV_ILN_2021 
912 |a GBV_ILN_2025 
912 |a GBV_ILN_2026 
912 |a GBV_ILN_2027 
912 |a GBV_ILN_2034 
912 |a GBV_ILN_2037 
912 |a GBV_ILN_2039 
912 |a GBV_ILN_2044 
912 |a GBV_ILN_2050 
912 |a GBV_ILN_2055 
912 |a GBV_ILN_2056 
912 |a GBV_ILN_2057 
912 |a GBV_ILN_2061 
912 |a GBV_ILN_2068 
912 |a GBV_ILN_2093 
912 |a GBV_ILN_2107 
912 |a GBV_ILN_2108 
912 |a GBV_ILN_2111 
912 |a GBV_ILN_2113 
912 |a GBV_ILN_2116 
912 |a GBV_ILN_2119 
912 |a GBV_ILN_2129 
912 |a GBV_ILN_2190 
912 |a GBV_ILN_2446 
912 |a GBV_ILN_2507 
912 |a GBV_ILN_2869 
912 |a GBV_ILN_2938 
912 |a GBV_ILN_2949 
912 |a GBV_ILN_2950 
912 |a GBV_ILN_4012 
912 |a GBV_ILN_4035 
912 |a GBV_ILN_4037 
912 |a GBV_ILN_4046 
912 |a GBV_ILN_4112 
912 |a GBV_ILN_4125 
912 |a GBV_ILN_4126 
912 |a GBV_ILN_4242 
912 |a GBV_ILN_4246 
912 |a GBV_ILN_4249 
912 |a GBV_ILN_4251 
912 |a GBV_ILN_4305 
912 |a GBV_ILN_4306 
912 |a GBV_ILN_4307 
912 |a GBV_ILN_4313 
912 |a GBV_ILN_4322 
912 |a GBV_ILN_4323 
912 |a GBV_ILN_4324 
912 |a GBV_ILN_4325 
912 |a GBV_ILN_4326 
912 |a GBV_ILN_4333 
912 |a GBV_ILN_4335 
912 |a GBV_ILN_4338 
912 |a GBV_ILN_4346 
912 |a GBV_ILN_4367 
912 |a GBV_ILN_4392 
912 |a GBV_ILN_4393 
912 |a GBV_ILN_4700 
912 |a GBV_ILN_4753 
936 b k |a 44.10  |q ASE 
951 |a AR 
952 |d 44  |j 2006  |e 4  |h 320-327